Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)

R. A. Larson; A. Hochhaus; T. P. Hughes; R. E. Clark; G. Etienne; D. W. Kim; I. W. Flinn; M. Kurokawa; B. Moiraghi; R. Yu; R. E. Blakesley; N. J. Gallagher; G. Saglio; H. M. Kantarjian

doi:10.1038/leu.2012.175

Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)

R. A. Larson
, A. Hochhaus
, T. P. Hughes
, R. E. Clark
, G. Etienne
, D. W. Kim
, I. W. Flinn
, M. Kurokawa
, B. Moiraghi
, R. Yu
, R. E. Blakesley
, N. J. Gallagher
, G. Saglio
, H. M. Kantarjian

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	2302
Number of pages	1
Journal	Leukemia
Volume	26
Issue number	10
DOIs	https://doi.org/10.1038/leu.2012.175
Publication status	Published or Issued - Oct 2012

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2012.175

Cite this

Larson, R. A., Hochhaus, A., Hughes, T. P., Clark, R. E., Etienne, G., Kim, D. W., Flinn, I. W., Kurokawa, M., Moiraghi, B., Yu, R., Blakesley, R. E., Gallagher, N. J., Saglio, G., & Kantarjian, H. M. (2012). Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175). Leukemia, 26(10), 2302. https://doi.org/10.1038/leu.2012.175

@article{065dc926a3dc4642934fe2a793a1031e,

title = "Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)",

author = "Larson, \{R. A.\} and A. Hochhaus and Hughes, \{T. P.\} and Clark, \{R. E.\} and G. Etienne and Kim, \{D. W.\} and Flinn, \{I. W.\} and M. Kurokawa and B. Moiraghi and R. Yu and Blakesley, \{R. E.\} and Gallagher, \{N. J.\} and G. Saglio and Kantarjian, \{H. M.\}",

year = "2012",

month = oct,

doi = "10.1038/leu.2012.175",

language = "English",

volume = "26",

pages = "2302",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "10",

}

Larson, RA, Hochhaus, A, Hughes, TP, Clark, RE, Etienne, G, Kim, DW, Flinn, IW, Kurokawa, M, Moiraghi, B, Yu, R, Blakesley, RE, Gallagher, NJ, Saglio, G & Kantarjian, HM 2012, 'Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)', Leukemia, vol. 26, no. 10, pp. 2302. https://doi.org/10.1038/leu.2012.175

Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175). / Larson, R. A.; Hochhaus, A.; Hughes, T. P. et al.
In: Leukemia, Vol. 26, No. 10, 10.2012, p. 2302.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)

AU - Larson, R. A.

AU - Hochhaus, A.

AU - Hughes, T. P.

AU - Clark, R. E.

AU - Etienne, G.

AU - Kim, D. W.

AU - Flinn, I. W.

AU - Kurokawa, M.

AU - Moiraghi, B.

AU - Yu, R.

AU - Blakesley, R. E.

AU - Gallagher, N. J.

AU - Saglio, G.

AU - Kantarjian, H. M.

PY - 2012/10

Y1 - 2012/10

UR - https://www.scopus.com/pages/publications/84867339732

U2 - 10.1038/leu.2012.175

DO - 10.1038/leu.2012.175

M3 - Comment/debate

AN - SCOPUS:84867339732

SN - 0887-6924

VL - 26

SP - 2302

JO - Leukemia

JF - Leukemia

IS - 10

ER -

Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this